Clinical Trial Update: Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a combination of sorafenib tosylate with bevacizumab, irinotecan hydrochloride, leucovorin calcium, and fluorouracil in metastatic colo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Adrucil (5-fluorouracil)
• Avastin (bevacizumab)
• Camptosar (irinotecan)
• Nexavar (Sorafenib)
• Wellcovorin (leucovorin calcium)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Colon Carcinoma, Recurrent Rectal Carcinoma | Phase 1 | Status: COMPLETED